↓ Skip to main content

Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds

Overview of attention for article published in Health and Quality of Life Outcomes, March 2014
Altmetric Badge

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds
Published in
Health and Quality of Life Outcomes, March 2014
DOI 10.1186/1477-7525-12-31
Pubmed ID
Authors

Vibeke Strand, Mark Kosinski, Ari Gnanasakthy, Usha Mallya, Shephard Mpofu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
Ireland 1 1%
Unknown 91 97%

Demographic breakdown

Readers by professional status Count As %
Other 11 12%
Student > Bachelor 10 11%
Student > Master 9 10%
Researcher 8 9%
Student > Ph. D. Student 7 7%
Other 21 22%
Unknown 28 30%
Readers by discipline Count As %
Medicine and Dentistry 38 40%
Nursing and Health Professions 9 10%
Biochemistry, Genetics and Molecular Biology 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Psychology 3 3%
Other 5 5%
Unknown 32 34%